Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Phase I Study Evaluating Safety, Pharmacokinetics, Pharmacodynamics, And Clinical Activity Of RO7119929 (TLR7 Agonist) In Participants With Unresectable Advanced Or Metastatic Hepatocellular Carcinoma, Biliary Tract Cancer, Or Solid Tumors With Hepatic Metastases

    • Cancer
    • Biliary Tract Cancer
    • Hepatocellular Carcinoma (HCC)